- Recent Funding
- Investors
- The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research portfolio
The Mark Foundation for Cancer Research has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Accent Therapeutics's $75M Series B+ round in January 2024, alongside EcoR1 Capital, Mirae Asset Venture Investment, Droia Ventures and 6 others. That company is in Health and bio. It has co-invested with GV, EcoR1 Capital and Droia Ventures, most often GV (2 rounds).
What The Mark Foundation for Cancer Research invests in
- Health and bio · 1 · 100%
How The Mark Foundation for Cancer Research invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 2 100% | $138M |
The Mark Foundation for Cancer Research portfolio companies
AAccent Therapeutics$75MSeries B+ · Jan 2024
| Company | Round with The Mark Foundation for Cancer Research | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $75M | $178M | Jan 23, 2024 Series B+ |
Most frequent co-investors
GGV2 shared rounds · last Jan 23, 2024
EEcoR1 Capital2 shared rounds · last Jan 23, 2024
DDroia Ventures2 shared rounds · last Jan 23, 2024
NNS Investment2 shared rounds · last Jan 23, 2024
TThe Column Group2 shared rounds · last Jan 23, 2024
MMirae Asset Capital1 shared round · last Jan 23, 2024
JJohnson & Johnson Innovation1 shared round · last Jan 23, 2024
MMirae Asset Venture Investment1 shared round · last Jan 23, 2024
MMirae Asset Capital Life Science1 shared round · last Jan 23, 2024
AAtlas Venture1 shared round · last Apr 23, 2020
AAbbVie1 shared round · last Apr 23, 2020
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 2 rounds on Recent Funding that name The Mark Foundation for Cancer Research. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists The Mark Foundation for Cancer Research, which is a subset of its real portfolio. API: /api/v1/investors/the-mark-foundation-for-cancer-research (get a free API key). More: the most active VC firms and new venture capital funds.